Peptides are short chains of amino acids, the building blocks of proteins, which play a crucial role in various bodily functions, including muscle growth and repair
Based on the February 2026 HHS announcement and analysis from compounding pharmacy and regulatory experts, the peptides expected to return to Category 1 status include BPC-157, Thymosin Alpha-1, TB-500, CJC-1295, Ipamorelin, AOD-9604, GHK-Cu, Selank, Semax, KPV, MOTS-C, and several others approximately 14 of the original 19 restricted compounds
KPV has strong mechanistic evidence from published research in Gastroenterology and other peer-reviewed journals, with well-characterized pathways (NF-kB inhibition, PepT1 transport) and positive results in established animal models of colitis
Currently, there is no conclusive research indicating an optimal time of day for BPC-157 administration
PEA is thought to work by supportingthe inflammatory response through the PPAR-a receptor, COX-2 and through effects on NF-kappaB signaling whilealso by restoring balance in the endocannabinoid system